Please join us in San Diego April 21 – 25 for the annual meeting of the American Society for Biochemistry and Molecular Biology, part of the Experimental Biology meeting. A wide range of scientists – from undergraduates to established senior investigators – will explore the breadth and depth of biochemistry and molecular biology through an exciting and comprehensive program we developed in collaboration with President Suzanne Pfeffer and the Program Planning Committee. The program includes award lectures honoring seminal scientific discoveries and achievements in biochemistry and molecular biology as well as exceptional plenary lectures.
The meeting will be composed of 11 thematic symposia that emphasize cutting-edge research in fields near and dear to the hearts of ASBMB members. These symposia consist of exciting lectures by invited speakers and short talks chosen from submitted abstracts. Special emphasis will be placed on choosing abstracts by undergraduate, graduate and postdoctoral trainees.
In this issue of ASBMB Today, we preview six of the scientific programs for the 2012 meeting. Look for more coverage in the November issue.
In this issue
The Gene Regulation theme, co-chaired by Karen Adelman (National Institute of Environmental Health) and Yang Shi (Harvard Medical School), will include sessions spanning several topics, including basic mechanisms for gene regulation, regulation of gene transcription during growth and development, the relationship between chromatin structure and transcription machinery, and histone modification and recognition.
The RNA theme, co-chaired by Manny Ares (University of California, Santa Cruz) and Tracy Johnson (University of California, San Diego), will highlight advances in the molecular understanding of mRNA splicing, dynamics of RNA folding, RNA-mediated regulation and regulation of ribosome-mRNA interactions.
DNA Replication, Recombination and Repair, co-chaired by Peter Baumann (Stowers Institute for Medical Research) and Patrick Sung (Yale University School of Medicine), will include sessions that focus on underlying mechanisms of DNA repair and replication and how these events are coupled. In addition, a session on the roles of telomeres and telomerase in chromosome integrity will be provided.
The Protein Synthesis, Targeting and Quality Control theme, co-chaired by Jeffrey Brodsky (University of Pittsburgh) and William M. Clemons (California Institute of Technology), will include sessions that cover the folding and assembly of ribosomes, mechanisms for targeting and translocation of proteins to ER membranes, factors modulating protein quality control, and the contribution of protein quality control to disease.
The Lipid and Lipid Signaling theme is co-chaired by Dawn L. Brasaemle (Rutgers University) and Timothy F. Osborne (Sanford-Burnham Medical Research Institute). This theme features sessions on lipid droplet biology, channeling of lipids and metabolic branch points, lipid signaling in infection and atherosclerosis, and lipid-mediated regulation of protein function.
The Metabolism and Disease theme, co-chaired by Reuben Shaw (Salk Institute) and Benjamin Tu (University of Texas Southwestern Medical Center at Dallas), will focus on organismal metabolism, signaling and metabolism, metabolism of cancer cells and aging metabolism.
In the November issue
Organelle Dynamics, co-chaired by David Chan (California Institute of Technology) and Benjamin Glick (University of Chicago), will consist of sessions that highlight the dynamics of mitochondria, quality control of organelles, secretory pathway organization and the dynamics of the endomembrane system.
The Glycobiology theme, co-chaired by Karen Colley (University of Illinois at Chicago) and Anant Menon (Weill Cornell Medical College), will focus on the role of glycoconjugates in signaling and development and in the invasion and virulence of pathogens. Additional sessions will highlight novel routes of glycoconjugate assembly and the roles of glycoconjugates in metabolism and disease.
Drug Development, co-chaired by Peter Jackson (Genentech) and Randall King (Harvard Medical School), will consist of sessions that explore the link between tumor regression and cell death, highlight advances in targeted cancer drug development, and discuss methods for discovery of new drug targets.
Systems Biology, co-chaired by Steve Altschuler (UT Southwestern Medical Center) and Alexander Hoffmann (UC, San Diego), will include sessions that will explore the construction of networks and will examine them as a function of time, space and noise within systems.
The Chemical Biology and Catalysis theme, co-chaired by Philip A. Cole (Johns Hopkins University School of Medicine) and Jason K. Sello (Brown University), will have sessions focused on metabolomics, chemistry and medicine, metabolic engineering and mechanistic enzymology.
The ASBMB Minority Affairs Committee will sponsor a special symposium on tuberculosis co-chaired by Clifton Barry (National Institutes of Health) and Squire Booker (Pennsylvania State University). Sessions will focus on the biochemistry of M. tuberculosis and mediators of host-pathogen interactions.
Finally, the ASBMB Education and Professional Development Committee will offer a symposium entitled “Maximizing Competitiveness During Challenging Economic Times.” This symposium, co-chaired by Peter Kennelly (Virginia Polytechnic Institute and State University) and Suzanne Barbour (Virginia Commonwealth University), will focus on maximizing institutional effectiveness, teaching effectiveness, marketability and global outreach.